This announcement is a separate document:
博瑞生物医药(苏州)股份有限公司主体及“博瑞转债”2024年度跟踪评级报告
Rating report on Borui Biomedical (Suzhou) Co., Ltd. and the "Borui Convertible Bonds" for the 2024 tracking year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.